Genomics gains momentum as breakthroughs, falling sequencing costs, and CRISPR advances drive precision medicine and fuel rapid market growth.

Modern technology could help lower barriers to developing therapies for rare diseases, writes Dr. Rowland Illing, chief ...

A research team led by Zhen-Xing Endowed Professor Jian Yang at the School of Life Sciences, Westlake University, together with collaborators, published their latest findings in Nature on April 1. The ...

A team at Rice University has built a lab platform that can map the activity of more than 10 million protein variants in a ...

I tried the $950 blood test Silicon Valley thinks can revolutionize cancer screening. The science—and my results—tell a ...

MINNEAPOLIS – A federally funded study aims to determine if whole-genome sequencing at birth can reduce childhood diseases and deaths while satisfying growing concerns over genetic privacy and public ...

Illumina fundamentals are improving, with FY26 expected to return to positive growth and enable operating leverage. Find out ...

New algorithms support Illumina TruPath™ Genome: v4.5 introdues analytical support for TruPath, leveraging algorithmic advances to resolve 15 highly homologous, medically-relevant genes for rare ...

(spidroins) through long-read transcriptomics across a broad phylogenetic range, with theoretical implications for protein family evolution, biomaterials, and silk biology. By identifying putative ...

New research suggests that autoimmune diseases may be driven by DNA mutations in immune cells that remove the natural brakes ...